Trinity Capital Inc. announced the commitment of $30 million in growth capital to Iantrek, a medical technology company and a leader in the bio-interventional ophthalmic surgery (BIOS) space.
Iantrek develops minimally invasive surgical technologies...
Read Story
April 29, 2026, 07:15 AM
|
Trinity Capital announced the commitment of $20 million in growth capital to Emboline, Inc. ("Emboline"), a MedTech company focused on reducing strokes and other complications during interventional heart procedures.Emboline's proprietary Emboliner®...
Read Story
March 12, 2026, 06:30 AM
|